Optimizing pharmacotherapeutic options for the treatment of depression

被引:0
|
作者
Cyr, M
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Depression is the most common psychiatric disorder in the United States, Many pharmacotherapeutic options are available for treating patients with depression, and they have shown success in up to 80% of cases. Successful pharmacotherapy involves not only correct choice of agent but also appropriate dosing, monitoring, and duration of therapy along with patient compliance, Successful therapy also depends on maintaining therapeutic closes while minimizing side effects. Although the onset of effect if the same for all antidepressants, the side effect profiles may vary considerably among agents. The side effect profile is also affected by the patient's concurrent medical conditions and concomitant drug regimens.
引用
收藏
页码:820 / +
页数:10
相关论文
共 50 条
  • [31] Treatment options for bipolar depression
    Bowden, CL
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 : 3 - 6
  • [32] Treatment options for refractory depression
    Shelton, RC
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 : 57 - 63
  • [33] Pharmacotherapeutic Options for Chronic Refractory Cough
    Song, Woo-Jung
    Chung, Kian Fan
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (11) : 1345 - 1358
  • [34] Pharmacotherapeutic options for pancreatic ductal adenocarcinoma
    Sardar, Muhammad
    Recio-Boiles, Alejandro
    Mody, Kabir
    Karime, Christian
    Chandana, Sreenivasa R.
    Mahadevan, Daruka
    Starr, Jason
    Jones, Jeremy
    Borad, Mitesh
    Babiker, Hani
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (18) : 2079 - 2089
  • [35] Current and promising pharmacotherapeutic options for candidiasis
    Scorzoni, Liliana
    Fuchs, Beth Burgwyn
    Junqueira, Juliana Campos
    Mylonakis, Eleftherios
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (07) : 867 - 887
  • [36] Current pharmacotherapeutic options for myasthenia gravis
    Barnett, Carolina
    Tabasinejad, Raha
    Bril, Vera
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (18) : 2295 - 2303
  • [37] Update on Pharmacotherapeutic Options for Rheumatoid Arthritis
    Eaton, Angie T.
    Davis, Portia N.
    Ndefo, Uche Anadu
    Ebiogwu, Adaora
    US PHARMACIST, 2013, 38 (10) : 44 - 48
  • [38] What are the pharmacotherapeutic options for adjustment disorder?
    Hoffman, Jacob
    Stein, Dan J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (06) : 643 - 646
  • [39] Pharmacotherapeutic options for the management of human polyomaviruses
    Roskopf, J
    Trofe, J
    Stratta, RJ
    Ahsan, N
    POLYOMAVIRUSES AND HUMAN DISEASES, 2006, 577 : 228 - 254
  • [40] EXPLORING PHARMACOTHERAPEUTIC OPTIONS FOR TREATING CHORDOMA
    Williams, B. J.
    Gupta, B.
    Sommer, J.
    Shaffrey, M. E.
    Park, D. M.
    DRUGS OF THE FUTURE, 2013, 38 (08) : 585 - 592